尼芬那宗结构式
|
常用名 | 尼芬那宗 | 英文名 | Nifenazone |
|---|---|---|---|---|
| CAS号 | 2139-47-1 | 分子量 | 308.33500 | |
| 密度 | 1.33g/cm3 | 沸点 | N/A | |
| 分子式 | C17H16N4O2 | 熔点 | 252-253° (also reported as mp 256-258°) | |
| MSDS | 中文版 美版 | 闪点 | N/A |
尼芬那宗用途Nifenazone 是一种吡唑类药物,可用于治疗各种风湿性疾病。 |
| 中文名 | 尼芬那宗 |
|---|---|
| 英文名 | N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)pyridine-3-carboxamide |
| 中文别名 | 烟酰氨基比林 |
| 英文别名 | 更多 |
| 描述 | Nifenazone 是一种吡唑类药物,可用于治疗各种风湿性疾病。 |
|---|---|
| 相关类别 | |
| 参考文献 |
[1]. HART FD, et al. TRIAL OF NIFENAZONE ("THYLIN"). Br Med J. 1964 Jun 13;1(5397):1553-4. |
| 密度 | 1.33g/cm3 |
|---|---|
| 熔点 | 252-253° (also reported as mp 256-258°) |
| 分子式 | C17H16N4O2 |
| 分子量 | 308.33500 |
| 精确质量 | 308.12700 |
| PSA | 68.92000 |
| LogP | 2.20470 |
| 折射率 | 1.671 |
| 储存条件 | 2-8°C |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 2 |
| RTECS号 | QS4005000 |
| 海关编码 | 2933990090 |
|
~%
尼芬那宗 2139-47-1 |
| 文献:Zorn; Schmidt Pharmazie, 1957 , vol. 12, p. 396,399 Full Text Show Details Heid Patent: DE897407 , 1951 ; Full Text Show Details Pongratz; Zirm Monatshefte fuer Chemie, 1957 , vol. 88, p. 330,332,333 |
|
~%
尼芬那宗 2139-47-1 |
| 文献:Zorn; Schmidt Pharmazie, 1957 , vol. 12, p. 396,399 |
|
~%
尼芬那宗 2139-47-1 |
| 文献:Pongratz; Zirm Monatshefte fuer Chemie, 1957 , vol. 88, p. 330,332,333 |
| 尼芬那宗上游产品 4 | |
|---|---|
| 尼芬那宗下游产品 1 | |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Temporal endogenous gene expression profiles in response to lipid-mediated transfection.
J. Gene Med. 17(1-2) , 14-32, (2015) Design of efficient nonviral gene delivery systems is limited as a result of the rudimentary understanding of the specific molecules and processes that facilitate DNA transfer.Lipoplexes formed with L... |
|
|
[Nifenazone, biotransformation in humans].
Arch. Pharm. (Weinheim) 318(9) , 855-63, (1985)
|
| Nicotazone |
| nifenazone |
| Nicoreumal |
| Nicazane |
| niphenazone |
| 1,5-Dimethyl-4-nicotinamido-2-phenyl-3-pyrazolone |
| N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-nicotinamide |
| Nicodone |
| Nicophesone |
| nicotinic acid-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamide) |
| Niapyrin |
| Nicotinsaeure-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamid) |
| Nicofesone |
| Nicophezon |
| Phenicazone |